A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics

Clinical trial NCT03019276 · UNKNOWN

Trial details

NCT number: NCT03019276
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2017-07-05
Primary completion: 2018-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.